Health Condition 1: G969- Disorder of central nervous system, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosis of Hemiplegic Stroke: Individuals with a confirmed diagnosis of hemiplegic stroke. 2. Adequate Cognitive Function: Participants must have sufficient cognitive function to understand and comply with the study requirements. 3. Time Since Stroke: Inclusion of participants who are within a specific time frame since the onset of stroke (e.g., between 3 and 12 months) to ensure a relatively homogenous sample. 4. Stable Medical Condition: Participants should be in a stable medical condition, without acute medical complications. 5. Trunk Impairments: Presence of trunk impairments, including but not limited to muscle weakness, limited range of motion, and coordination deficits. 6. Willingness to Participate: Willingness to participate in the study and adhere to the prescribed diaphragm manual therapy intervention and assessment protocols.
Exclusion criteria
Exclusion criteria: 1. Other Neurological Conditions: Exclusion of individuals with neurological conditions other than hemiplegic stroke. 2. Severe Cognitive Impairment: Exclusion of participants with severe cognitive impairment that may hinder their ability to comprehend and follow study instructions. 3. Unstable Medical Condition: Exclusion of individuals with unstable medical conditions, including uncontrolled hypertension or cardiac issues. 4. Pregnancy: Exclusion of pregnant individuals due to potential contraindications or safety concerns related to diaphragm manual therapy. 5. Previous Diaphragm Manual Therapy Within Study Period: Exclusion of participants who have undergone diaphragm manual therapy within a specified period before the study to avoid potential carryover effects. 6. Inability to Attend Sessions: Exclusion of individuals who are unable to attend the scheduled therapy sessions consistently. 7. Participation in Concurrent Clinical Trials: Exclusion of participants currently involved in other clinical trials to avoid potential confounding effects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.MAS (Modified Ashworth scale) 2.TIS (Trunk Impairment Scale) Timepoint: Baseline and 4th week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. FRT (Functional Reach Test) 2. FMYR (Fugl Meyer Assessment Timepoint: Baseline and 4th week | — |
Countries
India
Contacts
Ravi Nair Physiotherapy College, Datta Meghe Institute of Higher Education and Research (DU)